SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Integrated omics-driven discovery reveals synphilin-1-mediated anoikis resistance through p53 down-regulation.

Biosci Rep · 2026-10-01

DOI: 10.1042/bsr20260173PMID: 42695454

Open accessbrief-report; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Synphilin-1 is a protein that interacts with α-synuclein and has been implicated in Parkinson's disease (PD). However, the cellular and molecular mechanisms underlying the effect of synphilin-1 in PD remain poorly understood. The present study aimed to elucidate the molecular function of synphilin-1 using integrated transcriptomic and proteomic in silico analyses, followed by in vitro validation. Synphilin-1 overexpression enhanced cell viability and attenuated pathways associated with cell death. Among the identified regulatory molecules, p53 emerged as a key mediator linking synphilin-1 to suppression of anoikis. Notably, p53 expression demonstrated predominant nuclear localisation in midbrain tissues of individuals with PD. These findings suggest that synphilin-1 promotes cell survival by suppressing p53-mediated anoikis. This regulatory relationship could be crucial for understanding neuroprotective or pathological mechanisms in PD.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.